About

Clarity Surgical Advisors was founded to address a persistent gap in surgical innovation. Technologies now mature faster than the regulatory, clinical, and accountability systems needed to support their safe use at scale.

For advanced surgical domains in robotics, plastic and reconstructive surgery, and infection control, technical performance alone is insufficient. Outcomes are determined by how evidence is generated, how responsibility is assigned, and how risk is managed once devices transition from controlled trials into the operating room.

Clarity Surgical Advisors is led by Binita S. Ashar MD MBA, a former FDA Office Director and White House Special Advisor, and board-certified surgeon. Her perspective is grounded in firsthand experience at the intersection of federal regulation, frontline surgical care, and national health policy where abstract frameworks are tested by real-world consequences.

Background and Experience

• Former FDA Office Director, Surgical and Infection Control Devices

• Former White House Special Advisor for Medicine and Public Health

• Board-certified General Surgeon, Fellow of the American College of Surgeons and Member of the American College of Surgeons Academy of Master Surgeon Educators

• Board Member, Society of Robotic Surgery

Clarity Surgical Advisors applies this experience to advisory work focused on clinical readiness, accountability structures, and decision-making for complex surgical technologies, supporting companies, investors, and institutions navigating high-stakes adoption.